Lung Volume Reduction Surgery for Chronic Obstructive Pulmonary Disease (COPD)
Lung Volume Reduction Surgery (LVRS) is a surgical procedure in which sections of severely damaged lung tissue are removed. By removing the most diseased tissue (up to 30% of the lung volume), the goal is to improve the residual lung function and respiratory mechanics in patients with end-stage emphysema.
LVRS can be performed through either median sternotomy (open chest) or video-assisted minimally invasive technique. Studies show LVRS significantly improves quality of life, increases exercise capacity and even improves survival in carefully selected patients.
LVRS Capabilities at the Center for Chest Disease
NewYork-Presbyterian/Columbia University Medical Center is the only medical center in the tri-state area designated by the National Institutes of Health as a center of excellence in LVRS for the treatment of emphysema. Having performed LVRS for over a decade, NYP/Columbia is a major research and treatment center for lung volume reduction surgery and related airway procedures. The Center for Chest Disease has the experience to handle patient with the most complex conditions. The center offers all available modalities including LVRS, airway stenting, lung resection, and lung transplant. For more than eight years, the center has had a zero mortality rate in the 90-day period post-LVRS in patients meetingCMSapproval criteria.
If you are interested in being evaluated for lung volume reduction surgery, or to refer a patient, please call the Center for Chest Disease at 212.305.1158.
Kaplan-Meier estimates of cumulative probability of death as a function of years after randomization to LVRS (red line) or medical treatment (blue line) for patients with upper-lobe predominant disease and low baseline exercise capacity.*
* Reprinted from The Annals of Thoracic Surgery, Vol. 82. Naunheim KS, et al. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Copyright 2006, with permission from The Society of Thoracic Surgeons. All rights reserved.
** Washko GR, et al. The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med. 2008 Jan 15;177(2):164-9.
Madeline Gallagher, age 65, pre-op (left), and post-op (right), underwent LVRS at the Center for Chest Disease on October 17, 2007. Her treatment was featured in a November 28, 2007 New York Times feature on COPD and LVRS.